A comparative histological study on the uterovaginal junction in the laying hen in embryonated and non-embryonated egg producers

The uterovaginal junction, part of the reproductive duct, was studied in domestic hens, specifically the special tubular structures known as the sperm host gland. The results were compared between two groups—non-embryonated and embryonated egg producers. Relevant samples were collected, processed to paraffin wax blocks, and sections cut and stained with H&E and PAS stains. Two types of glands were observed in the lamina propria and submucosa. The results from the sperm host glands in chicken’s oviduct suggested that it might have a functional role in oviductal sperm storage in and release of spermatozoa from the sperm host glands of native hens. Sperm storage structures in the form of tubules are observed in the wall of the uterovaginal junction. These tubules are lined by both ciliated and secretory cells and may play a role in the storage of sperm. These features showed better development in the group of egg-laying hens producing embryonated eggs in comparison to the ones producing non-embryonated eggs.     

A histological study of the outer layer of rabbit fish (Siganus javus) eye

The rabbit fish is an economically valuable teleost species which lives in shallow coastal waters amongst aquatic plants. Two species of rabbit fish, Siganus sutore and Siganus javus, have been identified in the sea south of Iran. In this study, in order to investigate the histology of the outer layer of the S. javus eye, the eyes of 12 healthy specimens of S. javus were extracted and histologic sections were prepared. The sections were studied under a light microscope after staining with hematoxylin and eosin and Masson's trichrome stains. The outer layer was composed of the cornea cranially and the sclera caudally. The sclera contained an episclera zone and two cartilaginous segments with connective tissue correlation. The cornea included dermal components (stratified cuboidal epithelium, Bowman's membrane, and dermal stroma with occasional flattened cells); the scleral part consisted of two main layers (irregular fibers of connective tissue overlaying the second scleral stroma layer). The fibers of the scleral stroma were the only component present at the posterior part of the cornea. These results reveal that the eye of S. javus does not possess Descemet's membrane or endothelium in the cornea.     

Computer-aided dermoscopy for diagnosis of melanoma

Background

Recently, it has been observed that Video Display Terminals (VDTs) usage for long periods can cause some dermatological manifestations on the face. An analytical cross-sectional study was designed in order to determine this relationship.

Methods

In this study, 600 office workers were chosen randomly from an organization in Tehran (Iran). The subjects were then divided into two groups based on their exposure to VDTs. 306 workers were considered exposure negative (non VDT user) who worked less than 7 hours a week with VDTs. The remainders 294 were exposure-positive, who worked 7 hours or more with VDTs. The frequency of dermatologic manifestations was compared in these two groups.

Results

In the exposure-positive and exposure-negative groups, the frequency of these dermatologic manifestations were 27 and 5 respectively. After statistical analysis, a P.value of < 0.05 was obtained indicating a statistically significant difference between these two groups for dermatological manifestations.

Conclusion

According to our study, there is a relationship between dermatologic manifestations on the face and exposure to VDTs.     

Outcome of surgery on infants younger than 1 month with congenital glaucoma

PURPOSE: To determine the visual outcomes and surgical and anesthetic complication rates of patients with newborn glaucoma operated within 1 month of age. DESIGN: Retrospective, consecutive, noncomparative case series. PARTICIPANTS: All children with newborn glaucoma who underwent surgery between January 1990 and December 2000 were included. METHODS: The medical records of 25 consecutive patients (47 eyes) who underwent primary combined trabeculotomy and trabeculectomy either bilaterally in a single session or unilaterally were reviewed retrospectively. Outcomes were evaluated using Kaplan-Meier survival analysis. MAIN OUTCOME MEASURES: Clinical outcome assessment included corneal clarity, intraocular pressure (IOP), bleb characteristics, visual acuity, refractive errors, and identification of surgical and anesthetic complications. RESULTS: The mean follow-up was 3.1+/-1.8 years (range, 9.5 months-7.4 years). The mean preoperative IOP was 26.9+/-5.2 mmHg (range, 14-42 mmHg). At the final follow-up visit, the mean IOP was 14.5+/-3.8 mmHg (range, 8-28 mmHg). The percentage reduction in IOP was 43.3+/-21.5 (P<0.0001). Twelve-, 24-, and 36-month survival rates for complete success for IOP control were 89.4%, 83.6%, and 71.7%, respectively, which were maintained for 7 years of follow-up. After surgery, complete clearance of corneal edema was achieved in 66% of the eyes. Data on visual acuity was available for 19 patients. Final best spectacle-corrected visual acuity was 20/40 or better in the better eye in 5 patients (26.3%), 7 patients (36.8%) obtained 20/60 or better in the better eye, 8 patients (42.1%) achieved final visual acuity of less than 20/60 to 20/200 in the better eye (low vision), and four patients obtained less than 20/400 visual acuity in the better eye (blind) according to World Health Organization criteria. However, there was no eye with absent perception of light in the better eye. Myopia (mean spherical equivalent, 4.6+/-3.2 diopters) was the most common refractive error, present in approximately half of the eyes (n = 23; 53.8%). There were no significant intraoperative or postoperative complications in any patient. Anesthesia-related complications developed in 2 patients; however, they were resuscitated successfully. CONCLUSIONS: Primary combined trabeculotomy-trabeculectomy offers a viable surgical option in infants that have cloudy corneas at birth as a result of congenital glaucoma. It is associated with a favorable visual outcome and a low rate of anesthetic complications in an Indian population.     

Nanotechnology solutions for Alzheimer's disease: advances in research tools, diagnostic methods and therapeutic agents

A century of research has passed since the discovery and definition of Alzheimer's disease (AD), the primary common dementing disorder worldwide. However, AD lacks definite diagnostic approaches and effective cure at the present. Moreover, the currently available diagnostic tools are not sufficient for an early screening of AD in order to start preventive approaches. Recently the emerging field of nanotechnology has promised new techniques to solve some of the AD challenges. Nanotechnology refers to the techniques of designing and manufacturing nanosize (1-100 nm) structures through controlled positional and/or self-assembly of atoms and molecules. In this report, we present the promises that nanotechnology brings in research on the AD diagnosis and therapy. They include its potential for the better understanding of the AD root cause molecular mechanisms, AD's early diagnoses, and effective treatment. The advances in AD research offered by the atomic force microscopy, single molecule fluorescence microscopy and NanoSIMS microscopy are examined here. In addition, the recently proposed applications of nanotechnology for the early diagnosis of AD including bio-barcode assay, localized surface plasmon resonance nanosensor, quantum dot and nanomechanical cantilever arrays are analyzed. Applications of nanotechnology in AD therapy including neuroprotections against oxidative stress and anti-amyloid therapeutics, neuroregeneration and drug delivery beyond the blood brain barrier (BBB) are discussed and analyzed. All of these applications could improve the treatment approach of AD and other neurodegenerative diseases. The complete cure of AD may become feasible by a combination of nanotechnology and some other novel approaches, like stem cell technology.